Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.33251270 |
2 | L-phenylalanine catabolic process (GO:0006559) | 5.33251270 |
3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.29079479 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.16319972 |
5 | L-phenylalanine metabolic process (GO:0006558) | 5.16319972 |
6 | complement activation, alternative pathway (GO:0006957) | 4.95618139 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 4.92142460 |
8 | alpha-linolenic acid metabolic process (GO:0036109) | 4.85107462 |
9 | neutrophil activation involved in immune response (GO:0002283) | 4.69060864 |
10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.62522115 |
11 | protein carboxylation (GO:0018214) | 4.62522115 |
12 | regulation of protein activation cascade (GO:2000257) | 4.60428931 |
13 | indole-containing compound catabolic process (GO:0042436) | 4.58903010 |
14 | indolalkylamine catabolic process (GO:0046218) | 4.58903010 |
15 | tryptophan catabolic process (GO:0006569) | 4.58903010 |
16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58772230 |
17 | negative regulation of interleukin-12 production (GO:0032695) | 4.58469657 |
18 | response to peptidoglycan (GO:0032494) | 4.55667936 |
19 | sulfur amino acid catabolic process (GO:0000098) | 4.50513374 |
20 | glyoxylate metabolic process (GO:0046487) | 4.47864679 |
21 | regulation of complement activation (GO:0030449) | 4.47052749 |
22 | kynurenine metabolic process (GO:0070189) | 4.44357850 |
23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.41041803 |
24 | tryptophan metabolic process (GO:0006568) | 4.37725854 |
25 | bile acid biosynthetic process (GO:0006699) | 4.31104871 |
26 | negative regulation of fibrinolysis (GO:0051918) | 4.26887465 |
27 | regulation of triglyceride catabolic process (GO:0010896) | 4.23912785 |
28 | plasma lipoprotein particle clearance (GO:0034381) | 4.21841615 |
29 | reverse cholesterol transport (GO:0043691) | 4.20592531 |
30 | macrophage activation involved in immune response (GO:0002281) | 4.16229787 |
31 | regulation of fibrinolysis (GO:0051917) | 4.11936459 |
32 | regulation of cholesterol esterification (GO:0010872) | 4.10917239 |
33 | urea cycle (GO:0000050) | 4.07486044 |
34 | urea metabolic process (GO:0019627) | 4.07486044 |
35 | homocysteine metabolic process (GO:0050667) | 4.01656511 |
36 | phospholipid efflux (GO:0033700) | 4.00728634 |
37 | lysine metabolic process (GO:0006553) | 3.99373302 |
38 | lysine catabolic process (GO:0006554) | 3.99373302 |
39 | immunoglobulin mediated immune response (GO:0016064) | 3.98421812 |
40 | acylglycerol homeostasis (GO:0055090) | 3.98012198 |
41 | triglyceride homeostasis (GO:0070328) | 3.98012198 |
42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.96000830 |
43 | modulation by symbiont of host defense response (GO:0052031) | 3.96000830 |
44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.96000830 |
45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.96000830 |
46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.96000830 |
47 | modulation by symbiont of host immune response (GO:0052553) | 3.96000830 |
48 | cysteine metabolic process (GO:0006534) | 3.94326583 |
49 | amino-acid betaine metabolic process (GO:0006577) | 3.92386368 |
50 | glycosphingolipid catabolic process (GO:0046479) | 3.92192986 |
51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.84799868 |
52 | protein-lipid complex remodeling (GO:0034368) | 3.84799868 |
53 | macromolecular complex remodeling (GO:0034367) | 3.84799868 |
54 | detection of other organism (GO:0098543) | 3.78896239 |
55 | negative regulation of cell killing (GO:0031342) | 3.77977040 |
56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.77977040 |
57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.77827909 |
58 | nitrogen cycle metabolic process (GO:0071941) | 3.77106226 |
59 | fatty acid beta-oxidation (GO:0006635) | 3.74170703 |
60 | serine family amino acid catabolic process (GO:0009071) | 3.72863680 |
61 | bile acid metabolic process (GO:0008206) | 3.70613234 |
62 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65633848 |
63 | phospholipid homeostasis (GO:0055091) | 3.65455813 |
64 | fatty acid oxidation (GO:0019395) | 3.61091653 |
65 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60155273 |
66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60155273 |
67 | detection of bacterium (GO:0016045) | 3.58462015 |
68 | low-density lipoprotein particle clearance (GO:0034383) | 3.58047913 |
69 | lipid oxidation (GO:0034440) | 3.56436492 |
70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.56169149 |
71 | glycolipid catabolic process (GO:0019377) | 3.55843517 |
72 | regulation of mast cell degranulation (GO:0043304) | 3.55024340 |
73 | regulation of mononuclear cell migration (GO:0071675) | 3.54855782 |
74 | detection of molecule of bacterial origin (GO:0032490) | 3.54738958 |
75 | valine metabolic process (GO:0006573) | 3.54612539 |
76 | oligosaccharide catabolic process (GO:0009313) | 3.54506729 |
77 | aromatic amino acid family metabolic process (GO:0009072) | 3.52391657 |
78 | cellular ketone body metabolic process (GO:0046950) | 3.49774345 |
79 | detection of external biotic stimulus (GO:0098581) | 3.48458006 |
80 | positive regulation of lipid catabolic process (GO:0050996) | 3.47744684 |
81 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.46698478 |
82 | complement activation (GO:0006956) | 3.45301415 |
83 | tyrosine metabolic process (GO:0006570) | 3.45032713 |
84 | fatty acid catabolic process (GO:0009062) | 3.44765881 |
85 | alpha-amino acid catabolic process (GO:1901606) | 3.43075937 |
86 | negative regulation of cholesterol transport (GO:0032375) | 3.40310728 |
87 | negative regulation of sterol transport (GO:0032372) | 3.40310728 |
88 | regulation of cholesterol storage (GO:0010885) | 3.40247068 |
89 | cholesterol efflux (GO:0033344) | 3.39989057 |
90 | regulation of sequestering of triglyceride (GO:0010889) | 3.37752021 |
91 | regulation of cholesterol homeostasis (GO:2000188) | 3.37447575 |
92 | positive regulation of fatty acid oxidation (GO:0046321) | 3.36134486 |
93 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35515992 |
94 | protein activation cascade (GO:0072376) | 3.35045709 |
95 | plasma lipoprotein particle assembly (GO:0034377) | 3.34839147 |
96 | negative regulation of lipase activity (GO:0060192) | 3.33802573 |
97 | fibrinolysis (GO:0042730) | 3.33674923 |
98 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.32968585 |
99 | monocarboxylic acid catabolic process (GO:0072329) | 3.32028890 |
100 | amino sugar catabolic process (GO:0046348) | 3.31535569 |
101 | short-chain fatty acid metabolic process (GO:0046459) | 3.30958766 |
102 | T-helper 1 type immune response (GO:0042088) | 3.29582703 |
103 | ethanol oxidation (GO:0006069) | 3.28728361 |
104 | carnitine metabolic process (GO:0009437) | 3.27267350 |
105 | drug catabolic process (GO:0042737) | 3.27215206 |
106 | bile acid and bile salt transport (GO:0015721) | 3.25817760 |
107 | cellular amino acid catabolic process (GO:0009063) | 3.25544331 |
108 | complement activation, classical pathway (GO:0006958) | 3.25163023 |
109 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.25044974 |
110 | low-density lipoprotein particle remodeling (GO:0034374) | 3.23964594 |
111 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.23794024 |
112 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23297897 |
113 | cholesterol homeostasis (GO:0042632) | 3.22874446 |
114 | fatty acid transmembrane transport (GO:1902001) | 3.21785232 |
115 | 2-oxoglutarate metabolic process (GO:0006103) | 3.21317504 |
116 | positive regulation of mast cell degranulation (GO:0043306) | 3.19641366 |
117 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.19641366 |
118 | regulation of leukocyte degranulation (GO:0043300) | 3.19341117 |
119 | acetyl-CoA metabolic process (GO:0006084) | 3.19197103 |
120 | cellular modified amino acid catabolic process (GO:0042219) | 3.18940892 |
121 | lipoprotein metabolic process (GO:0042157) | 3.18923931 |
122 | sterol homeostasis (GO:0055092) | 3.18905615 |
123 | granulocyte activation (GO:0036230) | 3.18693629 |
124 | indolalkylamine metabolic process (GO:0006586) | 3.18674882 |
125 | amine catabolic process (GO:0009310) | 3.17570875 |
126 | cellular biogenic amine catabolic process (GO:0042402) | 3.17570875 |
127 | benzene-containing compound metabolic process (GO:0042537) | 3.17243682 |
128 | carboxylic acid catabolic process (GO:0046395) | 3.15963022 |
129 | organic acid catabolic process (GO:0016054) | 3.15963022 |
130 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.14226925 |
131 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13957953 |
132 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.13713379 |
133 | urate metabolic process (GO:0046415) | 3.13354442 |
134 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.13197565 |
135 | positive regulation of mast cell activation (GO:0033005) | 3.12521560 |
136 | drug transmembrane transport (GO:0006855) | 3.12100482 |
137 | macrophage activation (GO:0042116) | 3.11186789 |
138 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10187414 |
139 | opsonization (GO:0008228) | 3.10013872 |
140 | cellular glucuronidation (GO:0052695) | 3.09534974 |
141 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.08635412 |
142 | plasma lipoprotein particle organization (GO:0071827) | 3.07505500 |
143 | ceramide catabolic process (GO:0046514) | 3.07074152 |
144 | positive regulation of leukocyte degranulation (GO:0043302) | 3.06347664 |
145 | detection of biotic stimulus (GO:0009595) | 3.05342482 |
146 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03592648 |
147 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.00560452 |
148 | regulation of antigen processing and presentation (GO:0002577) | 2.98809781 |
149 | myeloid dendritic cell differentiation (GO:0043011) | 2.97477641 |
150 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96950295 |
151 | NIK/NF-kappaB signaling (GO:0038061) | 2.95955917 |
152 | neutrophil activation (GO:0042119) | 2.95367153 |
153 | regulation of macrophage chemotaxis (GO:0010758) | 2.95252677 |
154 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.93548598 |
155 | N-acetylneuraminate metabolic process (GO:0006054) | 2.91637895 |
156 | germinal center formation (GO:0002467) | 2.90099797 |
157 | barbed-end actin filament capping (GO:0051016) | 2.89837980 |
158 | angiotensin maturation (GO:0002003) | 2.87624558 |
159 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87471786 |
160 | myeloid cell activation involved in immune response (GO:0002275) | 2.87127148 |
161 | adhesion of symbiont to host cell (GO:0044650) | 2.86580393 |
162 | virion attachment to host cell (GO:0019062) | 2.86580393 |
163 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86502298 |
164 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.83944480 |
165 | regulation of mast cell activation (GO:0033003) | 2.82050936 |
166 | B cell mediated immunity (GO:0019724) | 2.81917009 |
167 | cellular response to type I interferon (GO:0071357) | 2.81250711 |
168 | type I interferon signaling pathway (GO:0060337) | 2.81250711 |
169 | microglial cell activation (GO:0001774) | 2.79792707 |
170 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.78541386 |
171 | response to type I interferon (GO:0034340) | 2.78173808 |
172 | cellular extravasation (GO:0045123) | 2.78005804 |
173 | response to muramyl dipeptide (GO:0032495) | 2.77685850 |
174 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77642857 |
175 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.77002369 |
176 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76707433 |
177 | myeloid dendritic cell activation (GO:0001773) | 2.75388091 |
178 | response to thyroid hormone (GO:0097066) | 2.75154181 |
179 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.74292510 |
180 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74094658 |
181 | mannose metabolic process (GO:0006013) | 2.73207039 |
182 | respiratory burst (GO:0045730) | 2.72223798 |
183 | regulation of podosome assembly (GO:0071801) | 2.71121410 |
184 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.71119320 |
185 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70840583 |
186 | defense response to protozoan (GO:0042832) | 2.68389769 |
187 | regulation of T cell tolerance induction (GO:0002664) | 2.67836470 |
188 | membrane lipid catabolic process (GO:0046466) | 2.67061529 |
189 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.62444847 |
190 | sphingolipid catabolic process (GO:0030149) | 2.61973911 |
191 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.61382650 |
192 | regulation of monocyte chemotaxis (GO:0090025) | 2.59195417 |
193 | regulation of interferon-alpha production (GO:0032647) | 2.57226673 |
194 | pinocytosis (GO:0006907) | 2.56867854 |
195 | response to protozoan (GO:0001562) | 2.56507571 |
196 | response to host immune response (GO:0052572) | 2.56250232 |
197 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.56250232 |
198 | regulation of chemokine biosynthetic process (GO:0045073) | 2.55420393 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.82441949 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.47121415 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.37433177 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.47625404 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.15110603 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.72918771 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.05170617 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.44511106 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.18777696 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.79600152 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.67260993 |
12 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.67114621 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64153288 |
14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.49362523 |
15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48805704 |
16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.41723667 |
17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.40765033 |
18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12681106 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07241787 |
20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04550328 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91124591 |
22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88398002 |
23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86939902 |
24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85843035 |
25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85785786 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84830941 |
27 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82966140 |
28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73798386 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73760845 |
30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73062844 |
31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70460038 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70058816 |
33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69758481 |
34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69567151 |
35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66565919 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66513249 |
37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.63907652 |
38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58492701 |
39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58200454 |
40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54535693 |
41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54422323 |
42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53794387 |
43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51309586 |
44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51079323 |
45 | MAF_26560356_Chip-Seq_TH1_Human | 1.49673540 |
46 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48063719 |
47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45955338 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.45891029 |
49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45783849 |
50 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41231619 |
51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40959234 |
52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39021712 |
53 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38797424 |
54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38794935 |
55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38271930 |
56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36886269 |
57 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36826326 |
58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36425031 |
59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31399923 |
60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31302725 |
61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31256389 |
62 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29024838 |
63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27899737 |
64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27662114 |
65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26391112 |
66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24869062 |
67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22270812 |
68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21906670 |
69 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21790868 |
70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21652022 |
71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19475738 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18706244 |
73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.18106227 |
74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18068908 |
75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16723584 |
76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16097521 |
77 | MYC_22102868_ChIP-Seq_BL_Human | 1.16080632 |
78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16019951 |
79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14796924 |
80 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14171970 |
81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10632871 |
82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08059910 |
83 | MAF_26560356_Chip-Seq_TH2_Human | 1.07663872 |
84 | MYB_26560356_Chip-Seq_TH2_Human | 1.07265326 |
85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07188127 |
86 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07169695 |
87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07159374 |
88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05878039 |
89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05878039 |
90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05033407 |
91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03054593 |
92 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00917873 |
93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99312331 |
94 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99143978 |
95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99003405 |
96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97019968 |
97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96810890 |
98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96488397 |
99 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96045224 |
100 | MYB_26560356_Chip-Seq_TH1_Human | 0.94784103 |
101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93327996 |
102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93098127 |
103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92369337 |
104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92362998 |
105 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92329868 |
106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92287208 |
107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91684537 |
108 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91618009 |
109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91608379 |
110 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90879992 |
111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90728353 |
112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90249370 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87973143 |
114 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85542088 |
115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85024072 |
116 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84533801 |
117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82229222 |
118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82229222 |
119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81960663 |
120 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80565287 |
121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77873514 |
122 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76438679 |
123 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.75720980 |
124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75678775 |
125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74977661 |
126 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.72675155 |
127 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72081758 |
128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71268135 |
129 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.71185897 |
130 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70824230 |
131 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70440071 |
132 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70411604 |
133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.67911648 |
134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67847224 |
135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67549842 |
136 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.66773642 |
137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.65951941 |
138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.64937873 |
139 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.63917078 |
140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62242304 |
141 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.61655484 |
142 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.60936977 |
143 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.60835042 |
144 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60476199 |
145 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.60443670 |
146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60359898 |
147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60095479 |
148 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59404738 |
149 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.57803429 |
150 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56465418 |
151 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.54981239 |
152 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.54342960 |
153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.54292860 |
154 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.54016797 |
155 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.53683988 |
156 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52870511 |
157 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.52596178 |
158 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.52551114 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.17731536 |
2 | MP0005360_urolithiasis | 5.52745529 |
3 | MP0005365_abnormal_bile_salt | 4.51111997 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.22540198 |
5 | MP0003303_peritoneal_inflammation | 4.15566169 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.49181604 |
7 | MP0003191_abnormal_cellular_cholesterol | 3.24306117 |
8 | MP0010329_abnormal_lipoprotein_level | 3.20195025 |
9 | MP0009840_abnormal_foam_cell | 3.15539294 |
10 | MP0003252_abnormal_bile_duct | 2.86860977 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.81052104 |
12 | MP0002148_abnormal_hypersensitivity_rea | 2.70929101 |
13 | MP0010368_abnormal_lymphatic_system | 2.67722364 |
14 | MP0005670_abnormal_white_adipose | 2.67597715 |
15 | MP0003172_abnormal_lysosome_physiology | 2.52879545 |
16 | MP0005025_abnormal_response_to | 2.42566697 |
17 | MP0003806_abnormal_nucleotide_metabolis | 2.38333364 |
18 | MP0005387_immune_system_phenotype | 2.35285881 |
19 | MP0001790_abnormal_immune_system | 2.35285881 |
20 | MP0005332_abnormal_amino_acid | 2.33262620 |
21 | MP0005000_abnormal_immune_tolerance | 2.31382819 |
22 | MP0003724_increased_susceptibility_to | 2.28731152 |
23 | MP0005671_abnormal_response_to | 2.20345190 |
24 | MP0004019_abnormal_vitamin_homeostasis | 2.18989450 |
25 | MP0004510_myositis | 2.10258225 |
26 | MP0000685_abnormal_immune_system | 2.06612956 |
27 | * MP0002452_abnormal_antigen_presenting | 1.94655076 |
28 | MP0000609_abnormal_liver_physiology | 1.91640382 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.90138429 |
30 | * MP0002723_abnormal_immune_serum | 1.88949465 |
31 | MP0003195_calcinosis | 1.88575551 |
32 | MP0002118_abnormal_lipid_homeostasis | 1.86812922 |
33 | MP0005083_abnormal_biliary_tract | 1.83985721 |
34 | * MP0001800_abnormal_humoral_immune | 1.83605991 |
35 | MP0002138_abnormal_hepatobiliary_system | 1.81654236 |
36 | MP0009278_abnormal_bone_marrow | 1.80249472 |
37 | MP0010155_abnormal_intestine_physiology | 1.77203723 |
38 | MP0001666_abnormal_nutrient_absorption | 1.75802861 |
39 | MP0005319_abnormal_enzyme/_coenzyme | 1.69546574 |
40 | * MP0002420_abnormal_adaptive_immunity | 1.67551365 |
41 | * MP0001819_abnormal_immune_cell | 1.67445175 |
42 | MP0004130_abnormal_muscle_cell | 1.67202268 |
43 | MP0005275_abnormal_skin_tensile | 1.63236547 |
44 | MP0005058_abnormal_lysosome_morphology | 1.59120053 |
45 | MP0001879_abnormal_lymphatic_vessel | 1.57186626 |
46 | MP0002405_respiratory_system_inflammati | 1.54902741 |
47 | MP0005397_hematopoietic_system_phenotyp | 1.49883022 |
48 | MP0001545_abnormal_hematopoietic_system | 1.49883022 |
49 | MP0004947_skin_inflammation | 1.49643143 |
50 | MP0002254_reproductive_system_inflammat | 1.46223943 |
51 | MP0009643_abnormal_urine_homeostasis | 1.43349031 |
52 | MP0005166_decreased_susceptibility_to | 1.43127509 |
53 | MP0005666_abnormal_adipose_tissue | 1.42947258 |
54 | MP0003183_abnormal_peptide_metabolism | 1.40292983 |
55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40086226 |
56 | MP0000858_altered_metastatic_potential | 1.39999262 |
57 | MP0003186_abnormal_redox_activity | 1.34729315 |
58 | MP0005310_abnormal_salivary_gland | 1.28723311 |
59 | MP0009333_abnormal_splenocyte_physiolog | 1.28477024 |
60 | MP0008260_abnormal_autophagy | 1.28326792 |
61 | MP0009764_decreased_sensitivity_to | 1.27901282 |
62 | MP0006054_spinal_hemorrhage | 1.27583018 |
63 | MP0003448_altered_tumor_morphology | 1.25670564 |
64 | MP0005167_abnormal_blood-brain_barrier | 1.24591733 |
65 | MP0003690_abnormal_glial_cell | 1.24318688 |
66 | MP0003279_aneurysm | 1.20008436 |
67 | MP0003329_amyloid_beta_deposits | 1.19264602 |
68 | MP0000604_amyloidosis | 1.17840781 |
69 | MP0004272_abnormal_basement_membrane | 1.17836480 |
70 | MP0003011_delayed_dark_adaptation | 1.17724307 |
71 | MP0001764_abnormal_homeostasis | 1.16758256 |
72 | MP0000716_abnormal_immune_system | 1.15841297 |
73 | MP0000465_gastrointestinal_hemorrhage | 1.09439274 |
74 | MP0003453_abnormal_keratinocyte_physiol | 1.08626930 |
75 | * MP0008469_abnormal_protein_level | 1.08190703 |
76 | MP0009763_increased_sensitivity_to | 1.07106525 |
77 | MP0003436_decreased_susceptibility_to | 1.05749293 |
78 | MP0000343_altered_response_to | 1.04425803 |
79 | MP0002971_abnormal_brown_adipose | 1.02809279 |
80 | MP0000598_abnormal_liver_morphology | 1.02531911 |
81 | MP0000013_abnormal_adipose_tissue | 1.01975611 |
82 | MP0005390_skeleton_phenotype | 0.98526521 |
83 | MP0001663_abnormal_digestive_system | 0.98521900 |
84 | MP0005451_abnormal_body_composition | 0.98514079 |
85 | MP0002837_dystrophic_cardiac_calcinosis | 0.97503284 |
86 | MP0003300_gastrointestinal_ulcer | 0.95187402 |
87 | MP0001533_abnormal_skeleton_physiology | 0.92808540 |
88 | MP0005334_abnormal_fat_pad | 0.92767209 |
89 | MP0005375_adipose_tissue_phenotype | 0.92042874 |
90 | MP0002876_abnormal_thyroid_physiology | 0.91854234 |
91 | MP0001756_abnormal_urination | 0.91743878 |
92 | MP0009697_abnormal_copulation | 0.91017991 |
93 | MP0002398_abnormal_bone_marrow | 0.90528600 |
94 | MP0005164_abnormal_response_to | 0.89709716 |
95 | MP0000249_abnormal_blood_vessel | 0.89575855 |
96 | MP0005503_abnormal_tendon_morphology | 0.89202612 |
97 | MP0000689_abnormal_spleen_morphology | 0.89075884 |
98 | MP0001853_heart_inflammation | 0.88851539 |
99 | MP0000920_abnormal_myelination | 0.88135010 |
100 | MP0002429_abnormal_blood_cell | 0.87918042 |
101 | MP0003075_altered_response_to | 0.87383074 |
102 | MP0001835_abnormal_antigen_presentation | 0.86812039 |
103 | MP0009115_abnormal_fat_cell | 0.86658101 |
104 | MP0002933_joint_inflammation | 0.86621085 |
105 | MP0001958_emphysema | 0.86204054 |
106 | MP0002295_abnormal_pulmonary_circulatio | 0.85573615 |
107 | MP0004185_abnormal_adipocyte_glucose | 0.85052137 |
108 | MP0005647_abnormal_sex_gland | 0.84845381 |
109 | MP0005636_abnormal_mineral_homeostasis | 0.84445856 |
110 | MP0002136_abnormal_kidney_physiology | 0.84144024 |
111 | MP0002419_abnormal_innate_immunity | 0.82797526 |
112 | MP0002060_abnormal_skin_morphology | 0.81619364 |
113 | MP0001851_eye_inflammation | 0.81188029 |
114 | MP0003866_abnormal_defecation | 0.80640298 |
115 | MP0002277_abnormal_respiratory_mucosa | 0.79433394 |
116 | MP0003795_abnormal_bone_structure | 0.79109405 |
117 | MP0004883_abnormal_blood_vessel | 0.79003714 |
118 | * MP0009642_abnormal_blood_homeostasis | 0.77935088 |
119 | MP0001661_extended_life_span | 0.77503301 |
120 | MP0002722_abnormal_immune_system | 0.77361637 |
121 | MP0008004_abnormal_stomach_pH | 0.76297941 |
122 | MP0005464_abnormal_platelet_physiology | 0.74714441 |
123 | MP0005084_abnormal_gallbladder_morpholo | 0.72569797 |
124 | MP0005165_increased_susceptibility_to | 0.72121133 |
125 | MP0001542_abnormal_bone_strength | 0.71254699 |
126 | MP0003091_abnormal_cell_migration | 0.70423154 |
127 | MP0004782_abnormal_surfactant_physiolog | 0.69758051 |
128 | MP0000230_abnormal_systemic_arterial | 0.69474382 |
129 | MP0005376_homeostasis/metabolism_phenot | 0.69194905 |
130 | MP0003868_abnormal_feces_composition | 0.68117198 |
131 | MP0005595_abnormal_vascular_smooth | 0.67476254 |
132 | MP0000490_abnormal_crypts_of | 0.67217093 |
133 | MP0002998_abnormal_bone_remodeling | 0.66894017 |
134 | MP0004858_abnormal_nervous_system | 0.66636355 |
135 | MP0005535_abnormal_body_temperature | 0.66389307 |
136 | MP0005381_digestive/alimentary_phenotyp | 0.65227477 |
137 | MP0003656_abnormal_erythrocyte_physiolo | 0.64752759 |
138 | MP0003879_abnormal_hair_cell | 0.64750592 |
139 | MP0000767_abnormal_smooth_muscle | 0.64712706 |
140 | MP0006082_CNS_inflammation | 0.63558390 |
141 | MP0002332_abnormal_exercise_endurance | 0.63179940 |
142 | MP0009384_cardiac_valve_regurgitation | 0.63081774 |
143 | MP0002078_abnormal_glucose_homeostasis | 0.62900203 |
144 | MP0009785_altered_susceptibility_to | 0.62290792 |
145 | MP0002132_abnormal_respiratory_system | 0.62094204 |
146 | MP0001873_stomach_inflammation | 0.62061934 |
147 | MP0003828_pulmonary_edema | 0.61173597 |
148 | MP0001243_abnormal_dermal_layer | 0.61135939 |
149 | MP0001845_abnormal_inflammatory_respons | 0.60020136 |
150 | MP0005023_abnormal_wound_healing | 0.59099217 |
151 | MP0003566_abnormal_cell_adhesion | 0.58712995 |
152 | MP0002168_other_aberrant_phenotype | 0.57943071 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.45826977 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.45826977 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.45826977 |
4 | Deep venous thrombosis (HP:0002625) | 5.71372422 |
5 | Complement deficiency (HP:0004431) | 5.64236457 |
6 | Xanthomatosis (HP:0000991) | 5.21406728 |
7 | Systemic lupus erythematosus (HP:0002725) | 4.95860755 |
8 | Abnormality of macrophages (HP:0004311) | 4.85782822 |
9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.79530021 |
10 | Intrahepatic cholestasis (HP:0001406) | 4.78880221 |
11 | Eczematoid dermatitis (HP:0000976) | 4.76845912 |
12 | Prolonged partial thromboplastin time (HP:0003645) | 4.74717507 |
13 | Increased cerebral lipofuscin (HP:0011813) | 4.73901671 |
14 | Abnormality of complement system (HP:0005339) | 4.52052162 |
15 | Recurrent abscess formation (HP:0002722) | 4.45415023 |
16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.44556019 |
17 | Recurrent bacterial skin infections (HP:0005406) | 4.31254181 |
18 | Joint hemorrhage (HP:0005261) | 4.24115031 |
19 | Hyperlipoproteinemia (HP:0010980) | 4.17654446 |
20 | Hyperglycinuria (HP:0003108) | 4.16427891 |
21 | Hypoalphalipoproteinemia (HP:0003233) | 4.03984606 |
22 | Loss of speech (HP:0002371) | 3.96368446 |
23 | Disinhibition (HP:0000734) | 3.92744826 |
24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.85421069 |
25 | Hyperammonemia (HP:0001987) | 3.84217980 |
26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.80270869 |
27 | Hypobetalipoproteinemia (HP:0003563) | 3.75431342 |
28 | Myositis (HP:0100614) | 3.74850768 |
29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.70144193 |
30 | Abnormality of glycine metabolism (HP:0010895) | 3.70144193 |
31 | Orchitis (HP:0100796) | 3.69506609 |
32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.68636151 |
33 | Hypolipoproteinemia (HP:0010981) | 3.68204342 |
34 | Glomerulonephritis (HP:0000099) | 3.61754056 |
35 | Hypoglycemic coma (HP:0001325) | 3.59064649 |
36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.55740773 |
37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.55740773 |
38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.55740773 |
39 | Ketosis (HP:0001946) | 3.54653409 |
40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.50854347 |
41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.46241611 |
42 | Hyperglycinemia (HP:0002154) | 3.42592479 |
43 | Mucopolysacchariduria (HP:0008155) | 3.40229033 |
44 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.40229033 |
45 | Epidermoid cyst (HP:0200040) | 3.38511910 |
46 | Mediastinal lymphadenopathy (HP:0100721) | 3.30246658 |
47 | Mutism (HP:0002300) | 3.27721592 |
48 | Retrobulbar optic neuritis (HP:0100654) | 3.24249455 |
49 | Optic neuritis (HP:0100653) | 3.24249455 |
50 | Myocardial infarction (HP:0001658) | 3.22327401 |
51 | Stomatitis (HP:0010280) | 3.05709233 |
52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.04765658 |
53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.04430820 |
54 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.04164266 |
55 | Neurofibrillary tangles (HP:0002185) | 3.04017995 |
56 | Obstructive lung disease (HP:0006536) | 3.01213512 |
57 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01213512 |
58 | Abnormality of the intrinsic pathway (HP:0010989) | 3.00862865 |
59 | Nonimmune hydrops fetalis (HP:0001790) | 2.98701778 |
60 | Hypercholesterolemia (HP:0003124) | 2.97548075 |
61 | Ketoacidosis (HP:0001993) | 2.91330032 |
62 | Nuclear cataract (HP:0100018) | 2.82490559 |
63 | Gingivitis (HP:0000230) | 2.79453850 |
64 | Fat malabsorption (HP:0002630) | 2.75019308 |
65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.74734996 |
66 | Dicarboxylic aciduria (HP:0003215) | 2.74734996 |
67 | Abnormality of purine metabolism (HP:0004352) | 2.74610756 |
68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.72242525 |
69 | Abnormality of methionine metabolism (HP:0010901) | 2.70978940 |
70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.70577126 |
71 | Autoimmune thrombocytopenia (HP:0001973) | 2.69213855 |
72 | Nephritis (HP:0000123) | 2.67899239 |
73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63651403 |
74 | Increased serum ferritin (HP:0003281) | 2.62000000 |
75 | Amyloidosis (HP:0011034) | 2.61723849 |
76 | Skin nodule (HP:0200036) | 2.60415152 |
77 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58452989 |
78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.57884125 |
79 | Generalized aminoaciduria (HP:0002909) | 2.57394523 |
80 | Vascular calcification (HP:0004934) | 2.54434761 |
81 | Petechiae (HP:0000967) | 2.51831505 |
82 | Hydroxyprolinuria (HP:0003080) | 2.51599497 |
83 | Abnormality of proline metabolism (HP:0010907) | 2.51599497 |
84 | Cardiovascular calcification (HP:0011915) | 2.50901674 |
85 | Recurrent skin infections (HP:0001581) | 2.50822252 |
86 | Pulmonary infiltrates (HP:0002113) | 2.50575469 |
87 | Hematochezia (HP:0002573) | 2.48477236 |
88 | Esophageal varix (HP:0002040) | 2.47117996 |
89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.40062778 |
90 | Conjugated hyperbilirubinemia (HP:0002908) | 2.38360270 |
91 | Mitral stenosis (HP:0001718) | 2.37589483 |
92 | Hepatosplenomegaly (HP:0001433) | 2.37424692 |
93 | Upper motor neuron abnormality (HP:0002127) | 2.37036253 |
94 | Hepatocellular carcinoma (HP:0001402) | 2.36329081 |
95 | Hypertriglyceridemia (HP:0002155) | 2.35558954 |
96 | Progressive neurologic deterioration (HP:0002344) | 2.34764462 |
97 | Broad metatarsal (HP:0001783) | 2.34265114 |
98 | Hemorrhage of the eye (HP:0011885) | 2.33418928 |
99 | Meningitis (HP:0001287) | 2.32368253 |
100 | Delayed CNS myelination (HP:0002188) | 2.32285927 |
101 | Vacuolated lymphocytes (HP:0001922) | 2.30275832 |
102 | Keratoconjunctivitis sicca (HP:0001097) | 2.29618082 |
103 | Hemoptysis (HP:0002105) | 2.29502983 |
104 | Hyperbilirubinemia (HP:0002904) | 2.28352908 |
105 | Axonal loss (HP:0003447) | 2.27289821 |
106 | Metabolic acidosis (HP:0001942) | 2.27162551 |
107 | Recurrent fungal infections (HP:0002841) | 2.25669702 |
108 | Vasculitis (HP:0002633) | 2.24806110 |
109 | Abnormality of serum amino acid levels (HP:0003112) | 2.24487867 |
110 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.24430864 |
111 | Neuronal loss in central nervous system (HP:0002529) | 2.21788629 |
112 | Nausea (HP:0002018) | 2.17775730 |
113 | Asymmetric septal hypertrophy (HP:0001670) | 2.17218899 |
114 | Urticaria (HP:0001025) | 2.16766542 |
115 | Gout (HP:0001997) | 2.16378935 |
116 | Pathologic fracture (HP:0002756) | 2.16108438 |
117 | Cerebral inclusion bodies (HP:0100314) | 2.13602874 |
118 | Proximal tubulopathy (HP:0000114) | 2.11391175 |
119 | Apathy (HP:0000741) | 2.10591425 |
120 | Pancreatitis (HP:0001733) | 2.09259227 |
121 | Diminished motivation (HP:0000745) | 2.09145992 |
122 | Spontaneous hematomas (HP:0007420) | 2.08645707 |
123 | Keratoconjunctivitis (HP:0001096) | 2.05871730 |
124 | Lethargy (HP:0001254) | 2.05231998 |
125 | Steatorrhea (HP:0002570) | 2.05087272 |
126 | Cellulitis (HP:0100658) | 2.04248582 |
127 | Pulmonary embolism (HP:0002204) | 2.03794377 |
128 | Protrusio acetabuli (HP:0003179) | 2.02935987 |
129 | Polycythemia (HP:0001901) | 2.01966963 |
130 | Increased IgE level (HP:0003212) | 2.01788057 |
131 | Premature rupture of membranes (HP:0001788) | 2.01503952 |
132 | Gastrointestinal infarctions (HP:0005244) | 2.01207742 |
133 | Peripheral demyelination (HP:0011096) | 2.00454439 |
134 | Peritonitis (HP:0002586) | 1.99551741 |
135 | Abnormal cartilage morphology (HP:0002763) | 1.99540460 |
136 | Hypoglycemic seizures (HP:0002173) | 1.98675598 |
137 | Agnosia (HP:0010524) | 1.98562895 |
138 | Inappropriate behavior (HP:0000719) | 1.98514281 |
139 | Increased purine levels (HP:0004368) | 1.98390307 |
140 | Hyperuricemia (HP:0002149) | 1.98390307 |
141 | Dementia (HP:0000726) | 1.97956963 |
142 | Vertebral compression fractures (HP:0002953) | 1.97781253 |
143 | Lymphangioma (HP:0100764) | 1.95594833 |
144 | Spontaneous abortion (HP:0005268) | 1.95238642 |
145 | Polyneuropathy (HP:0001271) | 1.94769690 |
146 | Epistaxis (HP:0000421) | 1.94487643 |
147 | Abnormality of the nasal mucosa (HP:0000433) | 1.93671326 |
148 | Personality changes (HP:0000751) | 1.92500197 |
149 | Basal ganglia calcification (HP:0002135) | 1.91638247 |
150 | Encephalitis (HP:0002383) | 1.90700739 |
151 | Vomiting (HP:0002013) | 1.90625193 |
152 | Sensorimotor neuropathy (HP:0007141) | 1.90525990 |
153 | Pustule (HP:0200039) | 1.90404830 |
154 | Increased CSF protein (HP:0002922) | 1.89567830 |
155 | Interstitial pulmonary disease (HP:0006530) | 1.86699279 |
156 | Thrombophlebitis (HP:0004418) | 1.86554497 |
157 | Prolonged neonatal jaundice (HP:0006579) | 1.86251432 |
158 | Retinal atrophy (HP:0001105) | 1.85429023 |
159 | Bone pain (HP:0002653) | 1.85165361 |
160 | Thoracic kyphosis (HP:0002942) | 1.83584553 |
161 | Abnormality of iron homeostasis (HP:0011031) | 1.83287671 |
162 | Malnutrition (HP:0004395) | 1.81479430 |
163 | Gingival bleeding (HP:0000225) | 1.80669688 |
164 | Restrictive lung disease (HP:0002091) | 1.80226124 |
165 | Alkalosis (HP:0001948) | 1.78781838 |
166 | Purpura (HP:0000979) | 1.78229572 |
167 | Enlarged kidneys (HP:0000105) | 1.76882769 |
168 | Conjunctival telangiectasia (HP:0000524) | 1.76809776 |
169 | Myoglobinuria (HP:0002913) | 1.76736427 |
170 | Episodic fever (HP:0001954) | 1.74424641 |
171 | Acrocyanosis (HP:0001063) | 1.74358405 |
172 | Acanthosis nigricans (HP:0000956) | 1.71954308 |
173 | Spastic diplegia (HP:0001264) | 1.71390563 |
174 | Irritability (HP:0000737) | 1.71296061 |
175 | Late onset (HP:0003584) | 1.71070254 |
176 | Neonatal onset (HP:0003623) | 1.71056612 |
177 | Dysostosis multiplex (HP:0000943) | 1.70869624 |
178 | Oligomenorrhea (HP:0000876) | 1.70728195 |
179 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69994201 |
180 | Menorrhagia (HP:0000132) | 1.68334409 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDR | 4.83255564 |
2 | TIE1 | 4.82465389 |
3 | BCKDK | 4.11214396 |
4 | ERN1 | 3.88258340 |
5 | TGFBR2 | 3.62066363 |
6 | RIPK4 | 3.11684055 |
7 | SIK1 | 2.79217439 |
8 | FGFR4 | 2.65384843 |
9 | TRIB3 | 2.45486670 |
10 | NME2 | 2.38402863 |
11 | BLK | 2.26657859 |
12 | CAMK1D | 2.21533246 |
13 | PRPF4B | 2.13643932 |
14 | TYK2 | 1.95595085 |
15 | TAOK1 | 1.92867105 |
16 | TAOK2 | 1.89001486 |
17 | FGR | 1.85050085 |
18 | MATK | 1.81958072 |
19 | NEK9 | 1.76827687 |
20 | INSRR | 1.76252943 |
21 | MST1R | 1.72246907 |
22 | JAK1 | 1.65177423 |
23 | PKN2 | 1.61413658 |
24 | FES | 1.59352353 |
25 | ACVR1B | 1.54913564 |
26 | TAOK3 | 1.52377347 |
27 | IRAK3 | 1.49877655 |
28 | EPHB1 | 1.48138152 |
29 | MYLK | 1.45687183 |
30 | MAP3K1 | 1.34038114 |
31 | MAP2K3 | 1.31803586 |
32 | RIPK1 | 1.31513137 |
33 | CAMK1G | 1.30398375 |
34 | FLT3 | 1.29105989 |
35 | TTN | 1.28557717 |
36 | CDC42BPA | 1.28381103 |
37 | TNK2 | 1.27920659 |
38 | PTK6 | 1.27740564 |
39 | TBK1 | 1.25813665 |
40 | TESK2 | 1.25470334 |
41 | JAK2 | 1.21822632 |
42 | SYK | 1.18485419 |
43 | MAP3K14 | 1.17722793 |
44 | MAP3K13 | 1.17722679 |
45 | MAP3K3 | 1.12437925 |
46 | EPHA3 | 1.12058530 |
47 | PRKAA2 | 1.10930152 |
48 | PIK3CG | 1.06769527 |
49 | BTK | 1.06353934 |
50 | HCK | 1.05200703 |
51 | EPHB2 | 1.04527877 |
52 | GRK1 | 1.02874044 |
53 | PIM2 | 1.02148584 |
54 | TESK1 | 1.02064070 |
55 | TXK | 1.00670520 |
56 | PDK2 | 0.95015380 |
57 | CSK | 0.92846876 |
58 | MAPK12 | 0.92787020 |
59 | PDGFRA | 0.92401507 |
60 | CAMKK2 | 0.90752472 |
61 | MAPK11 | 0.89927793 |
62 | MET | 0.89547514 |
63 | KIT | 0.87927411 |
64 | LCK | 0.85984543 |
65 | BMPR2 | 0.83582980 |
66 | GRK6 | 0.83193245 |
67 | JAK3 | 0.82669602 |
68 | FRK | 0.80715785 |
69 | ABL2 | 0.79375346 |
70 | TGFBR1 | 0.74819534 |
71 | LMTK2 | 0.74706115 |
72 | FGFR3 | 0.74374714 |
73 | SIK3 | 0.72570549 |
74 | MARK3 | 0.72253018 |
75 | GRK7 | 0.71736119 |
76 | CSF1R | 0.71397488 |
77 | MAP2K6 | 0.71009072 |
78 | PINK1 | 0.70282327 |
79 | IRAK2 | 0.69761943 |
80 | MAP4K1 | 0.69206071 |
81 | IKBKB | 0.69082685 |
82 | PIK3CA | 0.65528226 |
83 | CAMK4 | 0.65197083 |
84 | MAPK15 | 0.64979981 |
85 | PAK4 | 0.63708673 |
86 | PTK2B | 0.63630995 |
87 | IKBKE | 0.63565238 |
88 | MAP2K2 | 0.62695270 |
89 | RPS6KC1 | 0.62683609 |
90 | RPS6KL1 | 0.62683609 |
91 | FGFR2 | 0.62667111 |
92 | DAPK2 | 0.62012780 |
93 | MARK2 | 0.62008260 |
94 | MAPK7 | 0.61967873 |
95 | MAPK4 | 0.61897488 |
96 | MAP3K5 | 0.60571230 |
97 | PDK1 | 0.60133614 |
98 | PRKD2 | 0.59810099 |
99 | BMX | 0.58332905 |
100 | MAP2K1 | 0.56915472 |
101 | GSK3A | 0.56449122 |
102 | CHUK | 0.56225415 |
103 | CDK6 | 0.56084478 |
104 | PDK3 | 0.55395215 |
105 | PDK4 | 0.55395215 |
106 | IGF1R | 0.53637696 |
107 | LATS1 | 0.53519108 |
108 | TEC | 0.53228892 |
109 | FER | 0.53193844 |
110 | IRAK4 | 0.52742334 |
111 | ERBB4 | 0.52714974 |
112 | DYRK1B | 0.51086907 |
113 | ZAP70 | 0.50929728 |
114 | PRKG2 | 0.49779162 |
115 | ADRBK2 | 0.49328717 |
116 | RPS6KA6 | 0.49158002 |
117 | RPS6KA2 | 0.48915129 |
118 | ITK | 0.48765508 |
119 | STK38L | 0.48684515 |
120 | MUSK | 0.47682884 |
121 | DDR2 | 0.47366839 |
122 | KSR2 | 0.46593497 |
123 | MAP3K10 | 0.46255095 |
124 | IRAK1 | 0.45602686 |
125 | MAP3K6 | 0.45461084 |
126 | MAP3K7 | 0.45057276 |
127 | FYN | 0.44860279 |
128 | PRKAA1 | 0.43494598 |
129 | PTK2 | 0.42719807 |
130 | PRKACG | 0.42122358 |
131 | ICK | 0.40099459 |
132 | MAP2K4 | 0.39774218 |
133 | HIPK2 | 0.38831573 |
134 | PDPK1 | 0.38340339 |
135 | PRKD1 | 0.37377528 |
136 | CDK9 | 0.36259816 |
137 | LRRK2 | 0.35839809 |
138 | ARAF | 0.35266141 |
139 | PAK2 | 0.34889249 |
140 | PIM1 | 0.34148343 |
141 | SGK3 | 0.34131366 |
142 | ABL1 | 0.34102390 |
143 | LYN | 0.33380092 |
144 | MOS | 0.33208142 |
145 | SIK2 | 0.32962534 |
146 | MAPKAPK2 | 0.32267761 |
147 | STK10 | 0.31110423 |
148 | OBSCN | 0.29641468 |
149 | MAP3K11 | 0.29213632 |
150 | RET | 0.28045088 |
151 | TRPM7 | 0.27821686 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.74344068 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.10002934 |
3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.05336581 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90812797 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.84620593 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.74296331 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70021540 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.55312861 |
9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.54172415 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52438235 |
11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.51935590 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50764007 |
13 | Asthma_Homo sapiens_hsa05310 | 2.48964429 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46757160 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.38704799 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38536146 |
17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.29867085 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23896540 |
19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22066051 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.21899342 |
21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.18941341 |
22 | Peroxisome_Homo sapiens_hsa04146 | 2.11564614 |
23 | Tuberculosis_Homo sapiens_hsa05152 | 2.05694050 |
24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98322246 |
25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95806934 |
26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93731511 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91962125 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88105003 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.82549216 |
30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80668197 |
31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79486802 |
32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74661724 |
33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73342383 |
34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70209941 |
35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69629372 |
36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65745158 |
37 | Phagosome_Homo sapiens_hsa04145 | 1.63896054 |
38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59000543 |
39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.54613643 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48501380 |
41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45837657 |
42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45364859 |
43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44168595 |
44 | Bile secretion_Homo sapiens_hsa04976 | 1.43097255 |
45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41867484 |
46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40985946 |
47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.40047372 |
48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38873829 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38822403 |
50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35403938 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34731734 |
52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34712017 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33942451 |
54 | Salmonella infection_Homo sapiens_hsa05132 | 1.33849926 |
55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31553316 |
56 | Legionellosis_Homo sapiens_hsa05134 | 1.31143433 |
57 | ABC transporters_Homo sapiens_hsa02010 | 1.31043149 |
58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.30628181 |
59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23052265 |
60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20949511 |
61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20371788 |
62 | Influenza A_Homo sapiens_hsa05164 | 1.20362759 |
63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17807019 |
64 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17499622 |
65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17316693 |
66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15937324 |
67 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15603848 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.10134471 |
69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08565653 |
70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.08510237 |
71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06185354 |
72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05035495 |
73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02631984 |
74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01805371 |
75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97108312 |
76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94077607 |
77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91515146 |
78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90879458 |
79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90522913 |
80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.90391060 |
81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89007690 |
82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88533446 |
83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87098442 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86713451 |
85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84897548 |
86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80969556 |
87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79558063 |
88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77723199 |
89 | Measles_Homo sapiens_hsa05162 | 0.77700000 |
90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76732675 |
91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73900481 |
92 | Lysine degradation_Homo sapiens_hsa00310 | 0.73700998 |
93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73293472 |
94 | Shigellosis_Homo sapiens_hsa05131 | 0.71985725 |
95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69797183 |
96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69576033 |
97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69333686 |
98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67630537 |
99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66477786 |
100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66424390 |
101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65242688 |
102 | Apoptosis_Homo sapiens_hsa04210 | 0.64367738 |
103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63993994 |
104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63430453 |
105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63096824 |
106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61396339 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60336426 |
108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59582182 |
109 | Hepatitis B_Homo sapiens_hsa05161 | 0.59408865 |
110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58710572 |
111 | Bladder cancer_Homo sapiens_hsa05219 | 0.57869762 |
112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57863198 |
113 | Malaria_Homo sapiens_hsa05144 | 0.57699002 |
114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54050010 |
115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53190093 |
116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52878271 |
117 | Insulin resistance_Homo sapiens_hsa04931 | 0.52758307 |
118 | Lysosome_Homo sapiens_hsa04142 | 0.52458293 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52101853 |
120 | Platelet activation_Homo sapiens_hsa04611 | 0.50941460 |
121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47137467 |
122 | Prion diseases_Homo sapiens_hsa05020 | 0.46642155 |
123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46471856 |
124 | Endocytosis_Homo sapiens_hsa04144 | 0.45766666 |
125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40844555 |
126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40027849 |
127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40010626 |
128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36768641 |
129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35970305 |
130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35938059 |
131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35497079 |
132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34932350 |
133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32103201 |
134 | Pertussis_Homo sapiens_hsa05133 | 0.32082836 |
135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31869665 |
136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31288336 |
137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30400683 |
138 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30202675 |
139 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29414332 |
140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28921103 |
141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27902321 |
142 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25226451 |
143 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23397825 |
144 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.23393785 |
145 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21901994 |
146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21349788 |
147 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19297104 |
148 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18248650 |
149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17306275 |
150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15809173 |
151 | Amoebiasis_Homo sapiens_hsa05146 | 0.13678164 |
152 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11474433 |
153 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.10801322 |
154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10573673 |
155 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09990015 |
156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09060351 |
157 | Focal adhesion_Homo sapiens_hsa04510 | 0.05723089 |
158 | Mineral absorption_Homo sapiens_hsa04978 | 0.05372057 |
159 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.04881281 |
160 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.04354439 |
161 | Leishmaniasis_Homo sapiens_hsa05140 | 0.04145595 |
162 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.04139590 |
163 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03760127 |
164 | Hepatitis C_Homo sapiens_hsa05160 | 0.02250748 |